Labcorp Drug Development

Labcorp Drug Development is a contract research organization headquartered in Burlington, North Carolina, providing nonclinical, preclinical, clinical and commercialization services to pharmaceutical and biotechnology industries. Formerly called Covance, the company is part of Labcorp, which employs more than 70,000 people worldwide.

Labcorp Drug Development
Company typeSubsidiary of Labcorp
Industry
Founded1968 as Environmental Sciences Corporation; 1996 as Covance
HeadquartersBurlington, North Carolina, United States; facilities in 60+ countries
Key people
  • CEO: Paul Kirchgraber MD
  • CIO: Jonathan Shough
Services
  • Pharmaceutical Development
  • nonclinical, preclinical, clinical and commercialization services
Number of employees
70,000+ (2020)

Labcorp Drug Development offers services in the preclinical, clinical and post-market phases of drug development, the product life cycles for medical device and diagnostics and development services paired with regulatory support for the chemical testing and crop protection industries. Labcorp Drug Development claims to be a global leader in nonclinical safety assessment, clinical trial testing and clinical trial management services.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.